A Study to Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)

Study identifier:D3250R00062

ClinicalTrials.gov identifier:NCT04808518

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An observational Primary Data Collection Study to compare the lung function in the adult severe asthma patients who start biologics treatment and who do not start, after two-year follow-up

Medical condition

asthma

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

74

Study type

Observational

Age

n/a - n/a

Date

Study Start Date: 10 Dec 2019
Primary Completion Date: 27 Nov 2023
Study Completion Date: 27 Nov 2023

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jul 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria